Today: 9 April 2026
Barclays stock: €1bn bond redemption and buyback set up a key February test
10 January 2026
1 min read

Barclays stock: €1bn bond redemption and buyback set up a key February test

London, January 10, 2026, 09:14 GMT — Market closed

  • Barclays will redeem €1 billion of senior callable notes, with payment scheduled for Feb. 2 and the listing set to be cancelled soon after
  • Shares closed Friday at 484.9p, up 0.04%, hovering close to a 52-week high
  • UK GDP figures on Jan. 15 and labour data on Jan. 20 will influence the BoE decision on Feb. 5, alongside Barclays’ earnings report due Feb. 10

Barclays PLC (BARC.L) announced it will redeem €1 billion of senior callable notes on Jan. 31. Since that date falls on a non-business day, payment to holders is set for Feb. 2. The bank also plans to delist these notes from London on or shortly after that date. Barclays shares last closed Friday at 484.9 pence, up 0.04%, hovering about 2% below their 52-week peak. TradingView

With the London market closed for the weekend, investors will return Monday eager for direction ahead of Barclays’ full-year results. Capital returns and funding are once again under the spotlight, despite the stock showing little movement.

UK GDP figures will drop on Jan. 15, with labour market data set for Jan. 20—both capable of jolting rate expectations and bank stocks. For lenders, the crucial variable remains the net interest margin, which measures the difference between income from loans and costs on deposits. Office for National Statistics

Barclays revealed on Friday that it purchased 2,069,387 shares for cancellation at a volume-weighted average price of 483.2347 pence — this average factors in trade size. Since kicking off its buyback program on Oct. 23, the bank has snapped up roughly 63.1 million shares, according to its statement. Investegate

The stock has been stuck in a narrow range this week, hovering between 476.7 pence and 486.8 pence over the last two sessions. This pins 477p as the near-term support level, while 487p stands as the initial resistance. Beyond that, 500p is the next key round-number level to watch. Investing.com

Money markets now put an 88% probability on the Bank of England holding its benchmark rate at 3.75% at the Feb. 5 meeting, following a quarter-point cut in December, according to Reuters calculations derived from market pricing. Typically, a lower rate path weighs on banks’ interest income unless growth in loans and fees can fill the gap. Reuters

Alex Kerr, a UK economist at Capital Economics, said this week that GDP is set to grow just 1% in 2026. He added that easing inflation might allow the BoE to cut rates to 3.00% later this year. A bigger move in rate expectations could significantly impact UK lenders’ earnings and how investors value the sector. Capital Economics

But the risks pile up, some originating right here. The Financial Conduct Authority has put forward a motor finance redress scheme pegged at roughly 11 billion pounds. Lenders like Barclays, Lloyds, and Close Brothers are already boosting provisions as the plan takes shape. Reuters

February ramps up for Barclays, starting with the BoE decision on Feb. 5, followed by the bank’s full-year results set for Feb. 10. That earnings release will be the next major trigger for the stock. Bank of England

Stock Market Today

  • Guard Therapeutics Faces Potential Delisting from Nasdaq First North Growth Market
    April 9, 2026, 12:06 PM EDT. Guard Therapeutics International AB has been notified by Nasdaq that it currently fails to meet the active operations requirement, risking delisting by June 17, 2026. The company is exploring a merger or reverse acquisition to satisfy Nasdaq's operational criteria. A transaction structure is expected to be proposed in Q2 2024, allowing Nasdaq to reassess the listing status. If no agreement is reached, the board will recommend voluntary delisting and liquidation, returning available funds to shareholders. Final decisions will be taken by shareholders at a general meeting. Guard Therapeutics focuses on developing therapies for kidney diseases based on the alpha-1-microglobulin protein and is listed under the ticker GUARD.

Latest article

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

Palantir Stock Drops as Michael Burry Says Anthropic Is ‘Eating Its Lunch’

9 April 2026
Palantir Technologies dropped about 7% Thursday after Michael Burry said Anthropic was overtaking it in enterprise AI, putting Palantir on track to lose $34 billion in market value. Anthropic reported its annualized revenue run rate had surged past $30 billion and launched new AI tools for businesses. Nearly one in four businesses on Ramp now pays for Anthropic, according to Ramp data. Palantir’s stock still trades at 395 times earnings.
Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

Salesforce Stock Hits Fresh 52-Week Low Despite AI Growth and $50 Billion Buyback

9 April 2026
Salesforce shares hit a new 52-week low Thursday, dropping 3.7% to $169.76 despite reporting 12% revenue growth and strong demand for its AI products. The broader software sector continued to slide, with the S&P 500 software and services index down about $1 trillion since January. Salesforce raised its buyback authorization to $50 billion and increased its dividend to 44 cents a share.
ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

ServiceNow Stock Hits Fresh 52-Week Low as Analysts Cut Targets Ahead of Earnings

9 April 2026
ServiceNow shares dropped 5.1% to $92.45 by 10:20 a.m. EDT Thursday, hitting a new 52-week low after analysts at Stifel, BTIG, and Goldman Sachs cut price targets citing weak federal spending and limited 2026 growth. The company announced it will integrate AI, data, security, and governance into all products ahead of first-quarter results due April 22.
SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

SoFi Technologies Stock Slips as Wall Street Cuts Targets Ahead of Q1 Earnings

9 April 2026
SoFi Technologies shares fell 1.9% to $16.18 Thursday after KBW and Wells Fargo cut price targets ahead of first-quarter results due April 29. The moves follow Muddy Waters’ short position and claims of accounting issues, which SoFi denies. Affirm and LendingClub also traded lower. Barclays and other banks have trimmed targets as concerns mount over credit quality and sector valuations.
Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

Tesla revives cheaper EV bet with compact SUV plan in China after sales strain

9 April 2026
Tesla is developing a smaller, cheaper electric SUV to be built first in Shanghai, sources said. The new model would cost less than the Model 3 and be smaller than the Model Y. Tesla produced 408,386 vehicles but delivered only 358,023 in Q1, as U.S. demand weakened and competition increased. Shares fell 0.8% Thursday.
National Grid share price holds near 52-week high after Barclays target hike as Storm Goretti hits power networks
Previous Story

National Grid share price holds near 52-week high after Barclays target hike as Storm Goretti hits power networks

Ashtead Group (AHT) shares rise on buyback update as March NYSE relisting nears
Next Story

Ashtead Group (AHT) shares rise on buyback update as March NYSE relisting nears

Go toTop